BUNKER KEVIN D. (Chief Operating Officer) sold 5.3% of their position (10K shares) of ZENTALIS PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $599.9K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 1/20/2022ACC: 0001725160-22-000014
Officer· Chief Operating Officer
Since Apr 2020
-10K
Net shares
Net seller
$599.9K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
10K disposed
Non-Derivative Transactions3
Common Stock
Indirect
Shares
−2.75K
Price / share
$59.17
Trade value
$162.89K
% of position
1.4%
1/20/2022
190K→187.25K
Common Stock
Indirect
Shares
−6.54K
Price / share
$60.20
Trade value
$393.51K
% of position
3.5%
1/20/2022
187.25K→180.71K
Common Stock
Indirect
Shares
−710.00
Price / share
$61.29
Trade value
$43.52K
% of position
0.4%
1/20/2022
180.71K→180K
Total
Net shares
−10K
Net value
-$599.91K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 1/20/2022 | S · Sale | −2.75K | $59.17 | $162.89K | 1.4% | 190K | 187.25K |
| Common Stock Indirect | 1/20/2022 | S · Sale | −6.54K | $60.20 | $393.51K | 3.5% | 187.25K | 180.71K |
| Common Stock Indirect | 1/20/2022 | S · Sale | −710.00 | $61.29 | $43.52K | 0.4% | 180.71K | 180K |
| Total | −10K | -$599.91K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
DirectShares owned746.32K
Common Stock
IndirectShares owned350.00
Total
746.32K direct·350.00 indirect746.67K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 746.32K | Direct |
| Common Stock | 350.00 | Indirect |
| Total | 746.67K | 746.32K direct·350.00 indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported